Evaluation of Tranexamic Acid for Angiotensin-converting Enzyme Inhibitor-induced Angioedema in the Emergency Department

NCT06096077 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 50

Last updated 2024-01-18

No results posted yet for this study

Summary

Angiotensin-converting enzyme inhibitor ACEi induced angioedema ACEi-AE is defined as physical swelling of the deep skin layers or mucous membranes due to increased vascular permeability and leakage of fluid into the interstitial space caused while taking an ACEi

Conditions

  • Angioedema

Sponsors & Collaborators

  • Methodist Health System

    lead OTHER

Principal Investigators

  • Feng Lin, PharmD · Methodist Charlton Medical Center

Eligibility

Min Age
18 Years
Max Age
75 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2022-11-30
Primary Completion
2023-08-23
Completion
2023-08-23

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06096077 on ClinicalTrials.gov